Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Cytokine ; 169: 156306, 2023 09.
Article in English | MEDLINE | ID: mdl-37542834

ABSTRACT

The present study was designed as an exploratory investigation to characterize the overall profile of chemokines, growth factors, and pro-inflammatory/regulatory cytokines during acute DENV infection according to DENV-1, DENV-2, DENV-4 serotypes and age: children: <1-10-year-old (yo); adolescents:11-20 yo; adults 21-40 yo; and older adults: 41-75 yo. The levels of soluble immunemediators were measured in serum by high-throughput microbeads array in 636 subjects including 317 DENV-infected and 319 age-matching non-infected control (NI). Overall, most soluble mediators were increased in DENV-infected patients as compared to NI group regardless of age and DENV serotype, with high magnitude order of increase for CCL2, CXCL10, IL-1ß, IFN-γ, IL1-Ra (fold change >3x), except PDGF in which no fold change was observed. Moreover, despite the age ranges, DENV-1 and DENV-4 presented increased levels of VEGF, IL-6, and TNF-α in serum but decreased levels of PDGF, while DENV-2 exhibited increased levels of CXCL8, CCL4, and IL-12. Noteworthy was that DENV-2 showed increased levels of IL-12, IL-15, IL-17, IL-4, IL-9, and IL-13, and maintained an unaltered levels of PDGF at younger ages (<1-10 yo and 11-20 yo), whereas in older ages (21-40 yo and 41-75 yo), the results showed increased levels of CCL2, IL-6, and TNF-α, but lower levels of PDGF. In general, DENV infection at younger age groups exhibited more complex network immunoclusters as compared to older age groups. Multivariate analysis revealed a clustering of DENV cases according to age for a set of soluble mediators especially in subjects infected with DENV-2 serotype. Altogether, our findings demonstrate that the profile of circulating soluble mediators differs substantially in acute DENV according to age and DENV serotypes suggesting the participation of serotype-associated immune response, which may represent a potential target for development of therapeutics and could be used to assist medical directive for precise clinical management of severe cases.


Subject(s)
Dengue Virus , Dengue , Virus Diseases , Adolescent , Aged , Child , Child, Preschool , Humans , Infant , Cytokines , Dengue Virus/physiology , Immunity , Interleukin-12 , Interleukin-6 , Serogroup , Tumor Necrosis Factor-alpha , Young Adult , Adult , Middle Aged
2.
Article in Portuguese | LILACS-Express | LILACS, VETINDEX | ID: biblio-1491479

ABSTRACT

Os objetivos deste estudo foram determinar a prevalência de anticorpos inibidores da hemaglutinação para alfavírus em equinos investigados durante um surto ocorrido na Paraíba, em 2009, bem como comparar os resultados obtidos para o vírus da Encefalite Equina do Leste (EEE) mediante uso das técnicas de inibição de hemaglutinação e de soroneutralização em microplacas. Foi realizada coleta de sangue em 182 equídeos, distribuídos em 15 municípios da região oeste da Paraíba, onde existia relato da doença e/ou morte de equinos. Observou-se uma prevalência pré-teste para Encefalite Equina do Leste de 12,8%, prevalência real de 63,7% e prevalência aparente de 54,3%. Quando comparados os resultados obtidos no teste de inibição de hemaglutinação com o de soroneutralização, observou-se uma sensibilidade de 77,6% e especificidade de 86,4% no primeiro teste. Os valores preditivos positivos e negativos foram de 90,9% e 68,7%, respectivamente. O estudo revelou um grande número de animais infectados e sem manifestação clínica aparente.  Os resultados do teste de inibição de hemaglutinação associados as informações clínicas, epidemiológicas e ao diagnóstico virológico (detecção de genoma viral) foram capazes de confirmar a epizootia na área e demonstram que esta técnica pode ser recomendada como de triagem em inquéritos sorológicos desta natureza pela elevada sensibilidade e especificidade do

SELECTION OF CITATIONS
SEARCH DETAIL
...